In Competition Law and Policy Debate, Raphaël De Coninck highlights the European Commission’s recent interest in assessing the impact of pharmaceutical mergers on innovation. The article discusses the Commission’s approach and argues in favor of developing a consistent framework for assessing the impact of mergers on innovations. To read more, click the link below.
65 CRA consultants recognized in Who’s Who Legal: Consulting Experts & Thought Leaders 2024
CRA is pleased to announce that 65 consultants have been recognized in Who’s Who Legal: Consulting Experts & Thought Leaders 2024.